Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Extracorporeal membrane oxygenation industry 3600 synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Modality trends
2.1.3 Application trends
2.1.4 Patient population trends
2.1.5 Regional trends
Chapter 3 Extracorporeal Membrane Oxygenation Industry Insights
3.1 Industry landscape, 2018-2032
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increase in cases of cardiopulmonary disease and respiratory failure in Asia Pacific
3.2.1.2 Technological advancements in ECMO devices
3.2.1.3 Rising patient awareness about benefits delivered by extracorporeal membrane oxygenation devices in Latin America
3.2.1.4 Rising government initiatives and programs in Europe
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of equipment
3.2.2.2 Dearth of skilled professionals
3.2.2.3 Risks related to ECMO device
3.3 Growth potential analysis
3.3.1 By modality
3.3.2 By application
3.3.3 By patient population
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 ECMO procedure volume, by region
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.2 Competitive dashboard, 2021
4.3 Company market share, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Extracorporeal Membrane Oxygenation Market, By Modality
5.1 Key segment trends
5.2 Venoarterial (VA)
5.2.1 Market estimates and forecast, 2018-2032 (USD Million)
5.3 Veno-venous (VV)
5.3.1 Market estimates and forecast, 2018-2032 (USD Million)
5.4 Arteriovenous (AV)
5.4.1 Market estimates and forecast, 2018-2032 (USD Million)
Chapter 6 Extracorporeal Membrane Oxygenation Market, By Application
6.1 Key segment trends
6.2 Cardiac diseases
6.2.1 Market estimates and forecast, 2018-2032 (USD Million)
6.3 Respiratory diseases
6.3.1 Market estimates and forecast, 2018-2032 (USD Million)
6.4 Extracorporeal cardiopulmonary resuscitation (ECPR)
6.4.1 Market estimates and forecast, 2018-2032 (USD Million)
Chapter 7 Extracorporeal Membrane Oxygenation Market, By Patient Population
7.1 Key segment trends
7.2 Infant
7.2.1 Market estimates and forecast, 2018-2032 (USD Million)
7.3 Pediatric
7.3.1 Market estimates and forecast, 2018-2032 (USD Million)
7.4 Adult
7.4.1 Market estimates and forecast, 2018-2032 (USD Million)
Chapter 8 Extracorporeal Membrane Oxygenation Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Taiwan
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Qatar
8.6.4 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Fresenius Medical Care AG & Co. KGaA
9.3 Braile Biomedica
9.4 Edwards Lifesciences Corporation
9.5 Abiomed, Eurosets
9.6 Getinge AB
9.7 LivaNova PLC
9.8 Medtronic
9.9 MicroPort Scientific Corporation
9.10 Nipro
9.11 SB-Kawasumi Laboratories, Inc.
9.12 Spectrum Medical, Terumo Corporation
